A study published March 17 in JAMA Network Open found that transgender, nonbinary and gender-diverse people who were ...

Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and ...

J&J is discontinuing the Phase 3 test of its drug, aticaprant, in major depressive disorder “due to insufficient efficacy in the target patient population,” the company said after Thursday’s ...

In a statement released Thursday afternoon, J&J said it will stop developing the drug, called aticaprant, as an add-on ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says. About 40% of adults ...

University of Iowa Health Care is among only three academic medical centers in the nation, and the first in the Midwest, to ...

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good thing? And is depression weight loss even a thing in the first place?

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

Discover the crucial warning signs of retirement depression and learn effective strategies to maintain mental wellness during ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...